These qualified, off-the-shelf bioassays have been optimized for a particular drug and can reduce assay development timelines by at least 6 months. The simple, easy-to-use assay protocols deliver results fast, enabling implementation into QC lot release and transfer across sites globally.
Ready-to-use target- or MOA-based bioassays are optimized with a reference ligand. These assays can be readily implemented in development programs for drug candidates (biologics or small molecules) that use the same mechanism of action or the target.
These bioassays are currently in development and are also available as a custom assay development for customer-defined specifications. To request a custom bioassay for these biologics, email email@example.com.